CANNARA BIOTECH INC (LOVE.CA) Stock News

Canada - TSX Venture Exchange - TSX-V:LOVE - CA13765U2002 - Common Stock

1.7 CAD

+0.04 (+2.41%)

Last: 12/3/2025, 7:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

LOVE.CA Latest News, Press Relases and Analysis

All

Press Releases

10 days ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech réalise des revenus et une rentabilité records pour l’exercice 2025 et affiche pour la première fois un solde positif de bénéfices non répartis

10 days ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Delivers Record Fiscal 2025 Revenue and Profitability, Achieves First Year of Positive Retained Earnings

17 days ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. annoncera ses résultats financiers pour le quatrième trimestre de l'exercice 2025 et l'exercice 2025 le 24 novembre 2025 et fournit une mise à jour du conseil d’administration

17 days ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. to Announce Fiscal Q4 2025 and Fiscal Year 2025 Financial Results on November 24, 2025 and Provides Board Update

2 months ago - By: Cannara Biotech (Québec) Inc.

Cannara obtient l’admissibilité à la DTC afin de faciliter l’accès des investisseurs américains et renforce son bilan grâce à la conversion de sa dette en actions

2 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Announces DTC Eligibility to Facilitate U.S. Investor Access and Strengthens Balance Sheet through completion of Debt-to-Equity Conversion

2 months ago - By: Cannara Biotech (Québec) Inc.

Cannara annonce le règlement proposé de débentures convertibles par le biais d’une émission d’actions

2 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Announces Proposed Settlement of Convertible Debenture via Share Issuance

3 months ago - By: Cannara Biotech (Québec) Inc.

Cannara annonce l’octroi d’options d’achat d’actions et d’unités d’actions restreintes (RSU)

2 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Announces Proposed Settlement of Convertible Debenture via Share Issuance

3 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Announces Grant of Options and RSUs

3 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Announces Grant of Options and RSUs

4 months ago - By: Cannara Biotech (Québec) Inc.

Cannara annonce la modification et l’augmentation de la facilité de crédit accordée par BMO afin de soutenir l’expansion de ses installations à Valleyfield

4 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Announces Amendment and Upsize of BMO Credit Facility to Support Facility Expansion at Valleyfield

4 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Announces Amendment and Upsize of BMO Credit Facility to Support Facility Expansion at Valleyfield

4 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech renforce sa flexibilité financière grâce à la vente stratégique d'actifs

4 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale

4 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale

4 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech enregistre son chiffre d’affaires et sa rentabilité les plus élevés depuis sa création au troisième trimestre de l’exercice 2025

4 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Delivers Highest Revenue and Profitability Since Inception in Fiscal Q3 2025

4 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Delivers Highest Revenue and Profitability Since Inception in Fiscal Q3 2025

4 months ago - By: Cannara Biotech (Québec) Inc.

Cannara obtient 5 inscriptions clés dans la nouvelle catégorie de cartouches de vapotage de la SQDC, y compris des cartouches de vapotage à base de rosine vivante à venir

4 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Secures 5 Key Listings in Québec’s New Vape Cartridge Category Including to be Released Live Rosin Vapes

4 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Secures 5 Key Listings in Québec’s New Vape Cartridge Category Including to be Released Live Rosin Vapes

5 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. annoncera ses résultats financiers du troisième trimestre de l'exercice 2025 le 28 juillet 2025

5 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. to Announce Fiscal Q3 2025 Financial Results on July 28, 2025

5 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Inc. to Announce Fiscal Q3 2025 Financial Results on July 28, 2025

6 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech organise une webdiffusion pour les investisseurs le 25 juin 2025

6 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech to Host Investor Webcast on June 25th, 2025

6 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech to Host Investor Webcast on June 25th, 2025

6 months ago - By: Cannara Biotech (Québec) Inc.

Cannara réduit le coût de sa dette en abaissant son taux d’intérêt et en remboursant partiellement sa débenture convertible ; remporte le prix de la marque de l’année 2025

6 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year

7 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech affiche des résultats record au deuxième trimestre et accélère son expansion nationale

7 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates

7 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates

6 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year

8 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. annoncera ses résultats financiers pour le deuxième trimestre de l'exercice 2025 le 28 avril 2025

8 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025

8 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025

9 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech annonce la nomination de Justin Cohen au conseil d’administration